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1. Introduction 
RNA processing is an essential process in eukaryotic cells, creating different RNA species 
from one and the same gene. RNA processing occurs on nearly all kinds of RNAs, including 
mRNA that codes for proteins, ribosomal RNA, tRNA, snRNAs, and RNA. RNA 
processing usually occurs co-transcriptionally, and many factors are recruited by the RNA 
polymerase itself. This stimulates RNA processing by enhancing the correct assembly of 
factors as the RNA is being produced. Some factors, such as splice factors and cleavage 
factors for rRNA, are also recruited by the growing RNA-chain. A further link has been 
established by the transcription rate itself: the low processivity of the RNA polymerase, 
where it pauses a lot, favours inclusion of alternative splice sites, for instance. 
1.1 RNA processing in RNA polymerase II transcription 
RNA processing of the mRNA, 5' capping (addition of a methyl-guanosine at the 5' end), 
splicing (removal of internal introns) and polyadenylation (cleavage and polyadenylation of 
the 3’ end), are tightly coupled to transcription, and take place mainly co-transcriptionally 
(for review see Moore and Proudfoot, 2009; Wahl et al., 2009). The factors required for these 
processing events are recruited to the growing RNA chain during transcriptional elongation 
by specific sites or structures on the nascent RNA, the transcription machinery and the 
chromatin environment (for review see Moore and Proudfoot, 2009; Alexander and Beggs, 
2010; Luco et al., 2011; Schwartz and Ast, 2010; Carillo Oesterreich et al., 2011). Some of the 
factors necessary for RNA processing are also recruited by the RNA polymerase itself. RNA 
polymerase II has a C-terminal domain (CTD) with a repeated sequence of seven amino 
acids on the largest subunit, (Rbp1). The CTD forms a platform to which many different 
proteins involved in transcription may associate. The repeated sequence is conserved, 
YSPTSPS, in different organisms, whereas the length of the CTD is different, 52 residues in 
human cells and 26 in yeast. The CTD goes through a series of phosphorylations depending 
on where in the transcription cycle the polymerase is: unphosphorylated at the recruitment 
to the promoter, serine-5 phosphorylation (Ser-5) at promoter clearance (the first 20-40 
nucleotides) and serine-2 (Ser-2) phosphorylation on the elongating RNA polymerase II (for 
review see Meinhart et al. 2005; Buratowsky, 2009). Other modifications exist; Ser-7 
phosphorylation and the recently found argenine-3 phophorylation  play roles in snRNA 
and snoRNA transcription (Egloff et al., 2007; Kim et al., 2009; Sims et al., 2011), and Ser-7 
phosphorylation was recently found to be more abundant in intronic sequences (Hyunmin 
et al., 2010). The CTD cycle relies on kinases and phosphatases acting at the right moment 
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during transcription (review in Phatnani and Greenleaf 2006; Bukowski 2009). First the CTD 
is phosphorylated at Ser-5 at the promoter by the cdk7/kin28 in the RNA polymerase II 
auxiliary factor TFIIH, and this promotes promoter clearance. The shift into elongating 
mode is, at least partly, made by the dephosphorylation of Ser-5 by specific phosphatases, 
Rtr1 and Ssu72 and the phosphorylation of Ser-2 by cdk9 in the active P-Tefb complex in 
metazoan (ctk1 performs a similar task in yeast). Fpc1 is the phosphatase connected to 
dephosphorylation of Ser-2 of the CTD of RNA polymerase II. Recent studies have 
questioned these static events, and now a dynamic turnover of the phosphorylations  is put 
forward, in which an elongating RNA polymerase is predominantly Ser-2 phosphorylated 
but the Ser-5 is also phosphorylated to some extent (Burkowsky et al., 2009). 
1.1.1 The CTD of the RNA polymerase in RNA processing – recruitment versus 
elongation rate 
The concepts that the transcriptional elongation rate and recruitment of RNA processing 
factors through the CTD of RNA polymerase II are important for RNA processing have been 
known for some time (McCracken et al., 1997). Several proteins are recruited to transcription 
sites via association with the CTD, often depending on phosphorylation state (reviewed in 
Perales and Bentley, 2009). Capping of the nascent transcript occurs co-transcriptionally, as 
soon as the growing RNA leaves the exit channel of the RNA polymerase II. The enzymes 
involved in the capping machinery, at least Ceg1 in yeast, associate with the Ser-5-P CTD of 
the initiating RNA polymerase II (Komaninsky et al., 2000; Schroeder et al., 2000). The 
recruitment of 5’ capping machinery to the RNA polymerase enhances the capping reaction 
(Moteki et al. 2002), but it also has an influence on transcription. It has been suggested that 
the capping machinery or capping of the nascent transcript stabilises the RNA polymerase, 
which helps to convert the initiating polymerase to an elongating polymerase (Moore and 
Proudfoot, 2009; Perales and Bentley, 2009)). Termination and polyadenylation are also 
enhanced by the polyadenylating machinery associating with the Ser-2 phosphorylated CTD 
(Komanisnky et al., 2000; Adamson et al., 2002; Lunde et al., 2010).   
The spliceosome is assembled by different snRNPs being recruited by cis-acting sequences 
on RNA, the 5’ splice site and the 3’ splice site around introns. The recruitment of splicing 
factors occurs stepwise, with U1 snRNPs assembling on the 5’ splice site and U2 snSNP at 
the 3’ splice site, before the tri snRNP U4-U5/U6, assemble and the intron is removed (for 
review see Wahlet al., 2009; Moore and Proudfoot, 2009). The recruitment and assembly 
process of the different snRNPs is enhanced by transcription, and the complexes are further 
stabilised by the cap-binding complex (Lacardie et al., 2006; Listerman et al, 2006; 
Görnemann et al., 2005). A close coupling of the splicing to the transcriptional process has 
been seen also in several in vitro studies (Hicks et al., 2006, Das et al., 2006) in which 
transcription enhances splicing if the RNA polymerase II is transcribing and not T7 
polymerase, lacking the CTD. It has also been shown that some of these snRNPs and 
splicing factors associate with the RNA polymerase II itself, in particular U1 snRNPs and 
some SR proteins (Morris et al., 2000; Das et al., 2007) (Figure 1A). The U1 snRNP was 
recently shown to associate with the RNA polymerase II early in the transcription cycle, 
independently of whether the gene contains introns or not, an interaction that would allow 
the U1 snRNP to scan the growing RNA for splice sites (Brody et al., 2011). It can be seen 
that the amount of spliceosomes increases in intron-containing genes (Brody et al., 2011), 
most likely being recruited to the pre-mRNA by splice sites. These studies have led to the 
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proposal that spliceosomes are efficiently loaded onto the nascent transcript if recruited by 
RNA polymerase early in the transcription process, since the factors do not have to compete 
with inhibitory RNA-binding factors. However, the interactions between the CTD or other 
subunits of the RNA polymerase II and splice factors vary from study to study, which has 
questioned the generality of the results. It is possible that the interactions only occur on 
specific genes or in specific cell types (discussed in Carillo Oesterreich et al., 2011).  
It has also been shown that different promoters affect splicing differently, suggesting that 
different transcription factors at the promoter recruit specific splice factors. In particular, co-
regulators to nuclear receptors associate with splice factors, which in turn also act as 
transcription factors, regulating transcriptional initiation and elongation (Auboeuf et al., 
2004; Auboeuf et al, 2007). Splicing also enhances transcription, in particular at splice sites 
near the promoter (Furger et al,. 2002; Damgaard et al., 2008). Promoter proximal splice sites 
increase the binding of TFIID, TFIIB and TFIIH, all important general transcription factors 
for transcriptional initiation, and thereby increase loading and initiation of RNA polymerase 
II. Furthermore, the splice factor SC35, which is a splicing enhancer, associates with RNA 
polymerase and the cdk9 in the P-Tefb complex (Lin et al. 2008). Depletion of SC35 results in 
a transcription block, most likely caused by a lack of P-Tefb at the transcription site, which 
in turn leads to a severe reduction in Ser-2 phosphorylation of the CTD necessary for the 
switch to the elongating form of RNA polymerase II. Another example of a splice factor that 
interacts with P-Tefb is SKIP (prp45 in yeast) (Brès et al. 2005), which in this way influences 
transcriptional elongation.  
 
 
“5” denotes Ser-5 phosphorylation, “2” denotes Ser-2 phosphorylation, “splice” is splice factor. 
Fig. 1. The CTD affects splicing outcome, two models. A) The phosphorylation state of the 
CTD recruits splice factors. B) The phosphorylation state of the CTD affects the elongation 
rate of RNA polymerase II.  
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The RNA polymerase pauses during transcription, both near the transcription start site and 
locally inside the gene body. It is well established that the RNA polymerase II stalls 
proximal to the promoter, before switching from an initiation Ser-5 phosphorylated CTD 
mode to Ser-2 phosphorylated elongating mode (Brodsky et al., 2005). This is achieved by 
the recruitment of P-Tefb by the Ser-5 phosphorylated CTD, but also by histone 
modifications, such as H3K4me3 and H3Bub (for review Brés et al., 2008; Lenasi and 
Barboric, 2010) Pausing of RNA polymerases also occurs in the gene body (Figure 1B), local 
pausing, which may be achieved by a number of mechanisms: intrinsic features of the RNA 
polymerase II, such as backtracking, when the RNA polymerase II slides, elongation factors, 
and features in gene architecture, such as DNA sequences and structures formed in the 
growing RNA (review in Carillo Oesterrich et al,. 2011; Perales and Bentley, 2009). Several 
genome wide studies of the distribution of RNA polymerases have observed an 
accumulation at exons, suggesting a slower rate when the RNA polymerase meets an exon. 
It has been shown that paused RNA polymerase II is hyperphosphorylated, both Ser-5 and 
Ser-2 phosphorylation are present on the CTD (Munoz et al., 2008). Since both mutation of 
the CTD mimicking constant phosphorylation and inhibition of CDK9 induced a slower 
rate, it was suggested that homogenous phosphorylation is required achieved by altering 
the phosphorylation/dephosphorylation cycle (Munoz et al. 2008). The slower elongation 
rate often occurs at the 3’ splice site of introns, concomitant with hyperphosphorylation of 
the CTD and splice factor recruitment, as was shown in UV-damaged cells (Munoz et al. 
2008). Recent studies have also shown that the splicing event induces transcriptional 
pausing. The RNA polymerase accumulates in the Ser-5 CTD form at 3’ splice sites in the 
gene body (Alexander et al., 2010). Alexander et al. (2010) used a model gene in yeast with 
introns to map RNA polymerases with high resolution.  The stalling of RNA polymerase II 
was not observed in intronless genes or in genes with mutated splice sites. Alexander et al. 
(2010) suggest a check point control, related to splicing, in which such splice factors as SC35, 
Skip or DExD/H-box RNA helicases or even base-pairing between the snoU12 and the 
mRNA are involved. A similar mechanism has also been shown at the terminal exon in 
yeast, where an accumulation of RNA polymerase II is found (Carrillo Oesterrieich et al, 
2010). Intronless genes or genes with mutated splice sites do not have stalled RNA 
polymerases (Alexander et al. 2010; Carrillo Oesterreich et al., 2010). 
1.1.2 Alternative splicing – Recruitment versus the transcriptional elongation rate 
Splicing is a regulated process, and exons can be included or excluded giving different 
mRNAs, which generates a diversity of protein products. Alternative splicing is regulated 
by splice factors, such as specific SR protein and hnRNP proteins, which bind to specific 
sequences on RNA. Both splicing enhancer elements and splicing silencers exist and these 
sequences are found both in introns and exons (for review see Wahl et al., 2009). The splice 
factors can be expressed in a tissue-specific manner or can be activated by signalling 
pathways. In addition, core splice components are involved in alternative splicing, which 
has in some cases been attributed to production of different isoforms with specific function 
(Dredge et al, 2005) and in others to autoregulation coupled to degradation by the nonsense 
mediated decay pathway (Saltzman et al, 2008). Although a general splice factor is 
alternatively spliced and autoreguated, not all splicing events are affected. Recently, it was 
shown that the U1 core factor SmB7B’ is autoregulated, and its downregulation affects 
alternative splicing of several RNA processing proteins resulting in the reduction of snRNPs 
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(Saltzman et al., 2011). Another mechanism that affects splicing outcome is the transcription 
rate; pausing of the RNA polymerase favours inclusion of exons (Kornblihtt et al., 2004). 
This was shown by using a slow transcribing RNA polymerase II, which produced 
transcripts with more included exons (de la Mata et al., 2002). The slower rate gives time for 
splice factors to find the splice site, in particular the weak 3’ splice site upstream of 
alternative exons. Regulation of alternative splicing has therefore been suggested to rely on 
elongation rate, with pausing of the RNA polymerase II resulting in exon inclusion. It has 
been hard to find one general mechanism for alternative splicing, which sometimes is an all 
or nothing event, sometimes several alternative splice forms exist in the same cell. Many 
different factors are involved in splice site choice, many only being involved in a subset of 
genes. The complex regulation, both by specific alternative splice regulators, general splice 
factors and the transcription elongation rate, is a challenge. In addition, transcription occurs 
in a chromatin environment, with nucleosomes being present along the gene. This provides 
a further layer of regulation, in addition to splice factors and the transcription rate. 
1.2 Chromatin influences RNA processing 
Co-transcriptionally RNA processing occurs in a chromatin environment. Chromatin 
constitutes a barrier for transcription, both initiation and elongation. Several ways of 
changing the structure occurs upon transcription; the nucleosomes are moved and histones 
in nucleosomes are modified. Histone acetylation and H3K4me3 are particularly abundant 
at promoters, creating an open chromatin structure so that TFIIB and the RNA polymerase 
can bind. These modifications drop towards the 3’ end of the gene. Instead H3K36me3 
appears. 
1.2.1 Nucleosome distribution at exons 
Several studies have suggested that the chromatin architecture influences RNA processing 
of RNA pol II genes. Based on DNA sequencing, Baldi et al. (1996) and Kogan and Trifinov 
(2005) suggested that exons have nucleosomes positioned at intron-exon junctions. Genome-
wide analyses using Mn-digested chromatin of CD4+ T cells before deep Solexa sequencing 
(presented in Schones et al., 2008) have shown that exons are more prone to harbour 
positioned nucleosomes than intronic regions (Tilgner et al., 2009; Schwartz et al., 2009: 
Andersson et al., 2009; Hon et al., 2009; Speis et al., 2009; Nahkuri et al., 2009; Chodavarapu 
et al., 2010). If the exon is longer than 147 bp (the number of nucleotides wrapped around 
the histone core), the positioned nucleosome has a position at the 3' end in chromatin from 
C. elegans (Kolasinska-Twister et al., 2009). The distribution observed in human cells differs; 
however, the peak observed is at the 5’ end of exons (Hon et al., 2009). The average exon 
length in human cells is approximately 150 bp, fitting the length of one nucleosome, but 
both shorter and longer exons exist. The discrepancy between studies may be attributed to 
the definition of exon length used. When analysing both shorter and longer exons a 
consensus arises: short exons (50 bp or shorter) do not contain a positioned nucleosome, 
long exons (more than 300 bp) have positioned nucleosomes at both the 5’ end and the 3’ 
end of exons (Schwartz et al., 2009; Andersson et al., 2009; Hon et al., 2009). The positioned 
nucleosomes are stronger in exons with weak splice sites, but pseudo-exons (with strong 
splice sites which are not used) are depleted of nucleosomes (Tilgner et al., 2009; Spies et al., 
2009). Schwartz et al. (2009) found that the occupancy was related to exon usage, with less 
nucleosomes on low-abundant alternative exons, and more in high abundant, constitutive 
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exons. The higher nucleosome occupancy in exons is a conserved feature, found in both Mn-
seq from C. elegans, Drosophila, mice, man, and in a number of other eukaryotes, such as 
fungi and plants. The position of the nucleosomes is explained by the DNA sequence, the 
higher GC-content of exons producing a favourable curvature in the DNA (Tilgner et al., 
2009; Schwartz et al., 2009; Speis et al., 2009). This has been suggested to be caused by codon 
bias to exclude long stretches of A-tracts in exons (Cohanif and Haran, 2009). Another 
explanation is provided by Schwartz et al. (2009), who found nucleosome exclusion 
sequences at the 3’ splice site, thereby shoving the nucleosome into the exon. The fact that 
transcription does not affect the position of the nucleosomes suggests that the underlying 
sequence determines the nucleosome pattern and form a mechanism to mark exons 
(Anderson et al., 2009; Chodavarapu et al., 2010). However, a study investigating three cell 
types, the erythroid K562, the monocytic U937 and CD14+ monocytes, showed that the 
pattern of positioned nucleosomes varies – a higher density over exons of expressed genes is 
seen in primary CD14+ cells, whereas the cell lines K562 and U937 displayed a lower 
density (Dahrma et al., 2010). More cell types must be investigated to resolve these matters; 
these results may reflect differences in cell type.  
The nucleosome distribution at polyadenylation site is also set, with a region around the 
polyadenylation signal being depleted of nucleosomes, and a region downstream with a 
higher enrichment of nucleosomes (Speis et al., 2009; Carrillo Oesterreich, 2010). The 
depletion of nucleosomes is not linked to the level of transcription, but the downstream 
nucleosomes depend on the level of usage of the polyadenlylation site: high-level usage has 
more nucleosomes 76-375 bp downstream of the polyadenylation site. 
1.2.2 Histone modifications at exons 
The nucleosome position is only markedly increased at exons compared to introns (1.5 fold) 
and this is not affected by transcription (discussed in Schwartz and Ast, 2010), which has 
lead to several studies correlated the nucleosome occupancy data with genome-wide ChIP-
seq of several histone modifications. Histone modifications are involved in the regulation of 
transcription initiation and elongation, where they change both the nucleosome structure 
and recruit factors. The connection of the nucleosome distribution data with data from 
histone modifications along genes identified the H3K36-me3 as a specific modification 
accumulated at exons, and more pronounced at exons in the 3’ end of the gene (Kolasinska-
Zwierz et al., 2009; Schwartz et al., 2009; Andersson et al., 2009; Hon et al., 2009). Tilgner et 
al. (2009) could not find a clear accumulation of H3K36me3 at exons, however, when 
adjusted to the distribution of nucleosomes. The conflicting results reported, mainly based 
on the same data, could be due to different normalisation criteria and different algorithms 
used when correlating data obtained with different techniques; MN-seq with ChIP-seq and 
ChIP-Chip data (discussed in Ringrose, 2010). Nevertheless, most studies identified H3K36-
me3 as a mark for exons, together with several other modifications, forming a modification 
code along genes (Table 1). H3K36me3 accumulation at exons in the gene body was also 
seen in expressed genes when Dhami et al. (2010) investigated the three different cell types. 
In this study, some histone modifications were excluded from exons in expressed genes; 
H3K9me2/3, H3K27me2/3. These cell types also display a specific modification pattern for 
exons in non-expressed genes, H3K27me3. A recent study has further examined the 
nucleosomal architecture at exon-intron junctions, based on published genome-wide MN 
digestion-seq and ChIP-seq surveys (Huff et al., 2010). A specific histone modification 
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pattern was identified in the 5’ end of the gene, different from the 3’ end of the gene. The 
genes were therefore divided into three parts; promoter region, 5’ end of the gene (up until 
the internal exons), and the 3’ end of the gene, to further map the chromatin landscape. The 
5’ intron-rich region had higher levels of H3K79me2, and also peaked in H2Bub. The 
H3K36me3 was higher in the 3’ exon-rich part of the gene, and peaked near exons and 
extended downstream.  
 
Promoter Exon 5’ Exon 3’ 
Alternative 
exons 
Silent exons
Excluded 
from exons 
introns 
pol II 
accumul. 
Ref. 
H3K4me3 
H2Bub 
H3K79me2
H3K4me2 
H3K36me3    H3K79me2?  
Huff el al. 
CD4+ 
H3K4me3  H3K36me3 H3K36me3   
H3K9me3? 
H3K4me3? 
 
Kolasinksa et 
al. 
C.elegans 
  
H3K36me3 
H3K27me1 
H3K36me3 
(H3K27me1
/3 
H3K36me1 
H3K4me1 
H3K9me1) 
H3K27me3 
H3K36me1 
H3K9me2/3
H3K9me2/3 
H3K27me2/3
 
Dhami et al. 
three cell 
lines 
H3K4me3 
at TSS 
H3K4me3 
H3K36me3 
H3K27me2 
  H3K9me3  no 
Speis et l. 
CD4+ 
  
H3K36me3 
H3K79me1 
H4K20me1 
H2BK5me1 
H3K36me3    At exons 
Schwartz et 
al.  
C.elegans 
  
H3K36me3 
Before 
normalisatio
n 
  H4K20me1   
Tilgner et al. 
CD4+ 
H3K4me3 
H3K9me1 
H3K36me3
H2BK5me1
H4K20me1
H3K36me3 H3K36me3 
H3K9me3 
in excluded
exons 
   
Hon et al. 
CD4+ 
  
H3K36me3 
H3K79me1 
H2BK5me1 
 
H3K36me3 
H3K27me2
/3 
   
Andersson et 
al.  
CD4+ 
       At exons 
Chodavarapu 
et al. 
Plants etc 
 
Table 1. Histone modifications found in different part of RNA polymerase II genes. 
Underlined modification means that it changes with level of transcription. Font size 
represents level of the histone modification relative to others in the same study. The 
predominant cell type used in the study is found under the reference.  
1.2.2.1 How are the histone modifications achieved and maintained?  
The distribution of the nucleosomal exon–intron pattern is mainly explained by the 
underlying DNA sequence, but the histone modifications varies along the gene, indicating 
that active mechanisms also apply to set and maintain the pattern. Nucleosome 
modifications at exon-introns follow the level of transcription, but not completely. Histone 
modifications are loaded onto the histone tails by modifying enzymes recruited to the site of 
action (reviewed in Gardner et al., 2011; Murr, 2010). Modifications associated with 
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promoters, acetylated histones and H3K4me3 are set by histone acetyl transferases (HATs) 
and the SET1/MLL/COMPAS methyl transferases, respectively. These modifications are 
then removed by histone deacetylases (HDACs) and demethylases (HMTs). HATs are often 
co-regulators at the promoter, and MLL is recruited to the promoter by Ser-5 CTD on the 
RNA polymerase II. However, sometimes histone modifications at the promoter do not 
depend on transcription, instead they prime the genes for transcription (Raisner et al., 2005; 
Kouskouti and Talianidis, 2005; Liber et al., 2010: Min et al., 2011). Other histone marks are 
more abundant in the gene body (Murr et. al., 2010; Bannister and Kouzarides, 2011). H3K36 
tri-methylations are achieved by HypB/setd2 (Set2 in yeast) methyl transferases (Edmunds 
et al., 2008), which in turn are recruited to the transcribed gene most likely by Ser-2 CTD on 
the elongating RNA polymerase II (Eissenberg et al. 2007). The occurrence of modifications 
specifically at exons raises the question of how these patterns are set. By comparing the 
patterns of genes at different expression levels in the three cell types investigated, Dhami et 
al. (2010) identified a priming event consisting of H3K27me3 and H3K36me1 at non-
expressed genes. These marks were then replaced by H3K36me3 and H3K27me1 during 
transcription, and the levels reflected the expression level of the gene. This study also 
demonstrated a difference in alternatively spliced exons, showing less H3K36me3 at 
less-included exons. This suggests that some of the modifications are set not only by events 
during transcription, such as the elongation rate of RNA polymerase II, but also by events in 
splicing.  
Huff et al. (2010) addressed the question of whether splicing per se can affect the nucleosome 
modification pattern, by investigating two genes that are alternatively spliced upon stimuli, 
YPEL5 and CD45. No effect on the H3K36me3 levels could be seen upon inclusion of the 
alternative exons, ruling out that splicing events are setting the marks. Instead, these marks 
are relatively stable, similar to histone marks at promoters where marks are present without 
active transcription. Based on these results, a model in which exons are defined, or primed, 
by histone marks  can be put forward. In this model the basic marks can shift according to a 
set pattern, H3K27me3 to H3K36me3, by active transcription, but not splicing. However, 
this model is based on only two studies and needs verification. It is also worth noting that 
exons have a higher degree of DNA methylation, both in plants and in human cells 
(Chodavarapu et al., 2010). Whether this is a result of a higher DNA methylation of 
nucleosomal DNA or an active recruitment of DNA-methylation enzymes at exons remains 
to be resolved. In addition, the question of how the priming of exons in non-transcribed 
exons is achieved remains to be investigated. 
1.2.2.2 The functional significance of the chromatin pattern 
The next question to be addressed is whether the nucleosome distribution and histone 
modifications associated with exon-introns play a functional role in splicing? Two ideas 
have been proposed: The nucleosomes form “speed bumps” for the RNA polymerase or the 
histone modifications on nucleosomes form recruitment platforms for splice factors (Figure 
2A and 2B). The “speed bump” model is related to the “kinetic model”, and presumes that 
nucleosomes constitute a barrier for the elongating RNA polymerase II, in particular that 
nucleosomes at exons make the polymerase pause more. An accumulation of RNA pol II is 
seen also over exons (Schwartz et al., 2009; Dhami et al., 2010; Chodavarapu et al., 2010), 
indicating that the higher nucleosome density at exons (Schwartz et al., 2009) or the identity 
of the specific modifications provides a barrier for the RNA polymerase and makes it pause 
(Dhama et al., 2010). The pausing of the RNA polymerase II will then allow for splice factors 
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to assemble onto the growing mRNA. The “recruitment model” instead proposes that the 
chromatin architecture, with different histone modifications, is involved in recruiting 
components of the spliceosome and splice factors, such as SR-proteins and hnRNPs. These 
proteins will then decide the splicing outcome by binding to the nascent RNA and direct the 
spliceosome to the right place. These two models will be discussed below. 
1.2.2.3 RNA polymerase rate in a chromatin environment and alternative splicing 
RNA polymerase II processivity has an affect on splice site choice, as can be seen in 
alternative splicing. Alternative exons are included with a slower moving elongating RNA 
polymerase II (de la Mata et al. 2003). Inclusion of alternative splice sites can also be seen in 
cells by using different inhibitors of transcription, such as 5,6-dichlorobenzimidazole, 1-b-D-
ribofuranoside (DRB), which inhibits b-Tefb from phosphorylating elongating RNA 
polymerase II, and camptothecin (CPT), an inhibitor of topoisomerase I (reviewed in 
Kornblihtt 2004; Kornblihtt 2007). The slower rate gives time for splice factors not only to 
find the strong splice site, but also weak splice sites surrounding alternative exons, and 
assemble the U2 snRNP before the appearance of a strong splice site (Figure 2A). However, 
the result of a slow RNA polymerase II may not always result in inclusion of alternative 
exons as also specific inhibitors of alternative splicing have time to be recruited to splicing 
silencers (Pagani et al. 2003). Whether changes in the elongation rate of RNA polymerase 
along a gene are a general mechanism to affect splicing outcome is still unclear. It is not yet 
established whether the elongation rate of RNA polymerase II changes at alternative exons 
at all genes, or whether this is a local effect seen in only a subset of genes. It has been shown 
that the processivity of RNA polymerase II is consistent during transcription, at 
approximately 3. 8 kb/min, independently of whether intron-rich regions or exon-rich 
regions are transcribed. This was measured on a few endogenous genes with long introns by 
qPCR coupled to the alleviation a DRB block of elongation by RNA polymerase II (Singh 
and Padgett, 2009). In a separate study using FRAP of GFP-RNA polymerase II on a model 
gene, Brody et al. (2011) found that the RNA polymerase rate is similar on intronless genes 
as it is on genes harbouring several exons/introns. On the other hand, unspliced 
polyadenylated mRNA remains at the gene locus until properly spliced. These studies did 
not address the question of RNA processivity on genes with alternatively included exons. 
Recently, Ip et al. (2011) showed that the elongation rate affects the inclusion of alternative 
splice sites in a subset of genes. From a mechanistic point of view, the exons affected 
displayed an accumulation of RNA polymerase II upstream of the exon, in agreement with 
paused polymerases. These exons were surrounded by weaker splice sites than other 
alternative exons, and followed by a strong 3’ splice site at the downstream exon. The genes 
harbouring alternative exons sensitive to a slower elongation rate were mainly involved in 
RNA processing and apoptosis, and the alternative exon usage often introduced a 
premature termination codon, marking the transcript for nonsense-mediated decay. 
The processivity or pausing of the RNA polymerase depends on several factors: the 
architecture of the gene, DNA sequences, and factors bound to DNA and chromatin. 
Nuclesomes affect the RNA polymerase rate, but depending on which histone modifications 
they carry, the effects are of different magnitudes. Acetylated nucleosomes, for example, 
increase the rate of elongation by increasing the accessibility of DNA, whereas repressive 
methylation modifications reduce the RNA polymerase processivity. It has been shown that 
histone modifications alter the splice site choice, for instance that inhibiting histone 
deacetylases (HDACs) , creating hyperacetylated nucleosomes, results in the exclusion of 
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alternative exons at the 5’ end of the gene (Kornblihtt 2003; Allo 2011). This was attributed to 
an increase in H3-Ac at the 5’ end of genes. Recently, it was shown that an increase in H4-Ac 
at alternative splice sites in the gene body increases RNA polymerase II processivity, which 
in turn favours exclusion of the alternative exons (Hnilicavá et al. 2011). The HDAC 
inhibitor also reduces the association of the SR-protein SRp40 with chromatin/RNP, maybe 
also affecting splice factor acetylation. It has also been shown that inducing repressive 
histone marks, H3K9me2, by siRNA slows RNA polymerase II, and exons in the proximity 
of the recessive mark are included (Allo et al. 2010; Allo et al. 2011). The kinetic model 
connected to the genome-wide results predicts that H3K36me3, maybe together with other 
modifications or factors, decreases the RNA polymerase II processivity and leads to exon 
inclusion. The higher density of RNA polymerases at exons would favour such a model, but 
most studies find a lower H3K36me3 level at alternatively used exons than constitutively 
used exons. H3K36me3 is found on actively transcribed genes and follows the transcription 
level, which indicates that other factors must operate in addition to RNA processivity to 
determine exon usage. 
 
 
Fig. 2. Chromatin affects the splicing outcome, two models. A) Nucleosomes with 
modifications act as speed bumps affecting the elongation rate of RNA polymerase II. 
B) Histone modifications recruit splicing factors to splice sites. 
1.2.2.4 Splicing factor recruitment to chromatin in alternative splicing 
The recruitment model suggests that histone modifications constitute a platform for specific 
proteins to bind (Figure 2B). These proteins are chromatin-binding proteins that adopt an 
adapter function to recruit splice factors or they are splice factors that bind histone 
modifications directly. The capping machinery, for instance, binds not only to the CTD of 
the RNA polymerase, but also to the H3K4me3 found close to the promoters (Perales and 
Bentley, 2009). Four examples of chromatin factors functioning in splicing and possessing 
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the adapter function have been described, and these examples will be discussed below. The 
first one is a protein that is recruited to chromatin by binding to H3K36me3, MORF-related 
gene 15 (MRG15). The H3K36me3 is the major histone modification observed in transcribed 
exons, and it is tempting to suggest that the function is to attract specific factors to exons. 
H3K36me3 is recognised by MRG1, which interacts with the TIP60 HAT complex and 
HDACs. The yeast orthologue is involved in preventing promiscuous transcriptional 
initiation inside genes by removing acetyl groups formed around the elongating RNA 
polymerase II. The MRG15 protein also interacts with the H3K4me3 demethylase RBD2 
(retinoblastoma binding protein 2) on certain genes. Luco et al. (2010) connected MRG15 
with the PTB protein (polypyrimidine tract binding protein), which regulates the alternative 
splicing of certain transcripts by binding to a splicing silencer sequence on the RNA. MRG15 
interacts with PTB, and this interaction is used to recruit the PTB to alternative exons on a 
subset of genes. However, H3K36me3 is located at all exons, and also at included alternative 
spliced exons, so a splice-enhancing protein must exist that couples H3K36me3 to inclusion 
of exons. It is also hard to reconcile a model in which H3K36me3 is a marker for alternative 
exons with the pattern identified in genome-wide surveys, where all exons exhibited the 
mark.    
The chromatin remodelling ATPase CHD1 is recruited to active genes by binding to 
H3K4me3, and in turn interacts with the ATPase SNF2h and U2 spliceosome components 
(Sims et al. 2007). The CHD1 protein and H3K4me3 are not involved in changing splicing 
outcome, but rather the efficiency of the splicing reaction, suggesting that the recruitment of 
splicing factors is enhanced to splice sites. The H3K4me3 appears mainly at the 5’ end of 
genes and is not abundant in the 3’exon-rich part, (Spies et al. 2009), which suggests that the 
impact on splicing is restricted to the exons proximal to the promoter. However, H3K4me3 
has been identified on isolated exons in the 3’ end of genes in highly transcribed genes 
(Spies et al. 2009), and the question is whether the effects seen by CHD1 and H3K4me3 are 
on these exons. 
Acetylated histones have been correlated to an increased RNA processivity, but 
genome-wide studies have also shown a peak of H3K9-Ac just prior to exons in active genes 
(Dharma et al. 2010). The SAGA complex, with the HAT GCN5, interacts with acetylated 
histones, and recruits U2 snRNP proteins in yeast (Gunderson and Johnson 2009). Recently 
it was shown in yeast that deleting HDAC causes mis-regulation of the U2 snRNP along the 
gene body, suggesting that the dynamic acetylation-deacetylation cycle along the gene 
regulate spliceosome assembly (Gunderson et al. 2011). The deacetylation in the gene body 
is essential not only to prevent internal initiation of transcription but also to restrict 
splicosome assembly to exons.  
The fourth example of a chromatin protein that interacts with splice factors is the 
heterochromatin protein 1 (HP1). HP1, which associates with H3K9me3 in repressive 
chromatin, associates with hnRNPs in Drosophila cells, both in actively transcribed genes and 
in heterochromatin (Piacentini et al. 2009). It has been suggested that the role of HP1 in 
transcribed genes is not to affect the splicing reaction, but to be involved in the packaging 
and export of RNPs for a subset of genes. Recently, it was shown that phosphorylated HP1 
interacts with H3K9me3 in alternative exons in the CD44 gene in human cells (Saint-André 
et al. 2011). Activation of PKC, which phosphorylates HP1, results in the inclusion of the 
variable exons, a process that is reduced when HP1 is silenced. Simultaneously with the 
targeting of HP1, the RNA polymerase II and the splice factor U2AF65 are enriched at the 
variable spliced region of the gene. It has been proposed that HP1 acts as an adapter for 
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splicing factors, but the accumulation of RNA polymerase II suggests that it also reduces the 
processivity of RNA polymerase II. The histone modification pattern over this region 
contains peaks of H3K9me3, with low levels of H3K36me3. Most genome-wide studies show 
that H3K9me3 is excluded from exons in transcribed genes, but a genome-wide screen of 
histone methylations found a peak of H3K9me in the gene body (Barski et al., 2007). The 
discrepancy between the genome-wide studies and the CD44 gene regarding the presence of 
H3K9me3 could also be explained by the genome-wide surveys missing subsets of genes 
that exhibit a different histone modification pattern than the most prevalent ones, and also 
that cell type specific differences may exist. 
1.2.2.5 Chromatin remodelling factors in alternative splicing 
Chromatin remodelling complexes have also been implicated in RNA processing. 
Biochemically purified SWI/SNF complex interacts with several snRNP proteins and splice 
factors, such as Prp4 (Delaire et al. 2001) and Prp8 (Patrik Asp and Ann-Kristin Östlund 
Farrants, unpublished data). A functional role of the mammalian SWI/SNF ATPase 
proteins, BRM and BRG1, affects the splicing of specific genes. The SWI/SNF complexes are 
mainly involved in transcriptional initiation, remodelling the structure of nucleosomes at 
the promoter (for review Hargreaves and Crabtree, 2011). In addition, they have an effect on 
the splicing patterns of the CD44 gene and the telomerase gene (Batsche et al., 2006; Ito et al. 
2008). The mechanism behind the splicing effect has been attributed to an effect on the 
elongation rate of RNA polymerase II at the region containing various exons. The expression 
of BRM is to reduce the processivity of RNA polymerase by inducing a Ser-5 
phosphorylation of the CTD, while at the same time BRM interacts with the splicing 
regulator protein SAM68. SAM68 requires to be phosphorylated by PKC to bind to the 
nascent RNA and to BRM, which couples BRM and its effect on splicing to activation by 
external signals. The ATPase activity, which is required for chromatin remodelling, is not 
essential for the splicing effect. A number of genes have been identified, all of which rely on 
BRM for inclusion of alternative exons. However, the BRM on polytene chromosomes from 
the diphterian Chironomus tentans has been observed not only on chromatin but also on the 
growing mRNP (Figure 3A) (Tyagi et al., 2009), suggesting that the SWI/SNF complexes can 
influence splicing on several levels.  
 
 
Fig. 3. The ATPase BRM associates with both chromatin and the growing RNA. Left 
panel) Schematic view of a Balbiani ring gene in C. tentans, with growing RNP-particles. 
Right panel) EM images showing gold labelled BRM on Balbiani ring genes on the top, with 
drawings below. 
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The BRM also fractionates with the RNA fraction, as do the human BRG1 and BRM. Similar 
to BRM in human cells, SiRNA silencing of the Drosophila BRM affects the splice pattern of a 
subset of genes. Closer examination of these genes did not reconcile the splicing outcome on 
all genes affected with a slow transcription elongation rate. These variations led to the 
model presented in Figure 4A and 4B, which proposes that SWI/SNF complexes operate on 
two levels, one on chromatin by affecting the transcription elongation rate and one on RNA, 
most likely by associating to splice factors. A similar mechanism has been proposed for 
other chromatin proteins, such as the HATs PD20 and PCAF (Sjölinder et al., 2005; Obrdlik 
et al., 2008). 
 
 
 
Fig. 4. Models of chromatin remodelling in alternative splicing. A) SWI/SNF works at the 
chromatin level, slowing down the elongation rate. B) SWI/SNF associates with the growing 
mRNA. 
1.3 Summary 
It is clear that RNA processing is coordinated with transcription and chromatin 
environment. Firstly, several processing factors associate with the RNA polymerase II, or 
with chromatin proteins, suggesting that the processes are interlinked. Secondly, the 
transcriptional elongation rate affects splicing outcomes; several lines of evidence show that 
a pausing RNA polymerase II results in inclusion of exons, in particular at alternative exons 
with weak splice sites. One open question that still remains to be answered is how the RNA 
polymerase is slowing down at exons. One possible way of slowing down the elongating 
RNA polymerase is to change the phosphorylation state of its CTD, increasing its Ser-5 
phosphorylation. The mechanism behind this is not known, however. Is a Ser-5 kinase 
recruited at internal exons or is a phosphatase inactivated? The Ser-5 kinase TFIIH is found 
at the promoter, but it has been suggested that CDK9 in the p-Tefb functions as a Ser-5 
kinase in the gene body (Munoz et al., 2009). The yeast orthologue ctk1 has both Ser-5 and 
Ser-2 kinase activity (Jones et al., 2004). It has also been suggested that a change in the 
phosphorylation/dephosphorylation cycle contributes to the altered elongation rate (Munoz 
et al., 2009). Or is the phosphorylation secondary to sequences in the DNA, or backtracking 
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of the RNA polymerase? Moreover, the effect of chromatin and the histone modifications 
specific to exons and introns, on the elongation rate needs to be elucidated.  
The elongation rate of RNA polymerase II does not explain all splicing outcomes, and other 
mechanisms, such as recruitment of splicing enhancers and silencers to nascent RNA also 
contribute. In addition, chromatin remodelling proteins can be recruited to the nascent RNA 
and influence splice site choice. Recent studies have shown that chromatin landscape is 
involved in splicing; exons are denser in nucleosomes than introns and the histones at exons 
carry specific histone modifications.  In particular H3K36me3 are abundant in exons, the 
level is dependent on transcription. This mark is not affected by splicing events, suggesting 
a preset state, marking exons in a particular manner depending on exon usage, resulting in 
different patterns in different cell types. This raises several important questions. How are 
exon-intron histon marks set: by H3K36me3 specific methyl transferases or by demethylases 
being recruited? How are these modification enzymes recruited? The finding that expressed 
exons carry H3K36me3, whereas exons in non-expressed genes carry H3K27me3 suggests 
that the regulation of histones mark is even more complex. The studies presented show that 
chromatin and histone modifications constitute a further level of regulation of gene 
expression. 
2.1 Chromatin and ribosomal processing 
Ribosomal biogenesis employs a specific RNA polymerase machinery, employing specific 
processing and assembly factors. A large gene, the 47/45S rRNA gene, is transcribed by the 
RNA polymerase I, in the nucleolus, and from this transcript three of the four ribosomal 
RNAs in ribosomes; 18S, 5.8S and 28 S, are produced. The 4th rRNA is transcribed from a 
separate, small gene, by RNA polymerase III, in the nucleolus in yeast but in the 
nucleoplasm in metazoans. The nucleolus is the location also of rRNA processing and 
assembly. The ribosomal genes are present in tandem repeats, around 200 in yeast and 400 
in human cells, spread out on five chromosomes (for review Grummt and McStay, 2008). 
These gene loci constitute the nucleolar organisation centres (NORs) around which the 
nucleoli are formed after exit from mitosis when actively transcribed. RNA polymerase I 
transcription requires specific auxiliary factors, such as the UBF (upstream binding factor) 
and SL1 (selectivity factor 1), a TBP-containing complex. UBF binds to the rDNA promoter 
and recruits SL1, which in turn recruits the RNA polymerase I. The assembly of the 
transcription imitation complex is regulated by phosphorylation and acetylation of UBF and 
SL1 throughout the cell cycle through signalling pathways. UBF is a high motility group 
protein (HMG), which bends DNA in a similar manner to a nucleosome. UBF is found not 
only at the promoter but also along actively transcribed genes. The major fraction of the 
genes is not transcribed, however, and do not have UBF bound, or very low levels bound. 
Instead, these genes are organised into heterochromatin. 
2.1.1 RNA processing in RNA polymerase I transcription - rRNA processing 
The processing of the rRNAs involves cleavage of the transcripts and covalent 
modifications, such as pseudouridylation, 2’-O ribose methylation and base methylations 
(Decatur and Fournier, 2003; Henras et al., 2008). The processing of the rRNAs is initiated 
co-transcriptionally with the assembly of a “terminal knob”, which comprises the growing 
pre-rRNA with snoRNPs and modifying proteins. The pre-RNA is subsequently cleaved 
into the separate rRNAs by a number of exonucleases and endonucleases, which are helped 
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by snoRNA and RNA helicases, GTPases and kinases (Strunk and Karbstein, 2010; Kressler 
et al., 2010). The 47/45S is assembled with the snoRNPs U3, U8 and U13 (U14, snR30) and 
processing proteins, such as RNA helicases, cotransciptionally into the 90S pre-ribosomal 
particle (also called the “small subunit processome”, SSU). The essential snoRNA most 
likely binds to RNA and produces the right structure to the pre-RNA for further processing: 
the snoU3 binds to the ETS and ITS1 surrounding the 18S rRNA module by complementary 
base pairing, helicases are then required to dissociate the snoRNA during the maturation 
process (Bohnsack et al., 2008). SnoU3 binds early to the pre-RNA, together with several 
proteins important for the cleavage and modification of the 18S rRNA, and this part will 
later assemble into the 40S ribosome. The distal part of the rRNA, which will after cleavage 
of the 90S SSU form the LSU, large subunit processome, assembles later when the 5.8 and 
28S appears.  
Some proteins that assemble into the SSU are directly bound to the snoU3 RNP, the UTP (U 
three proteins). Seven UTPs in yeast form a separate subcomplex, t-UTP, which is associated 
with chromatin, affects transcription and is necessary for processing (Wery et al. 2009). A 
homologous complex is present in human cells, with six identified proteins (Prieto and 
McStay, 2007). The function of the t-UTPs on transcription and chromatin has not been fully 
worked out. It has been proposed that the t-UTP in yeast is involved in pre-RNA 
stabilisation rather than in RNA polymerase I transcription (Wery et al. 2009).  
2.1.2 The link between transcription and pre-RNA processing 
The pre-RNA processome contains proteins that affect both transcription and processing. 
This has led to the proposal that transcription and processing are coordinated and influence 
each another. The t-UTP complex would then be the first level of coordinating these events 
during transcription, since it is recruited early in the process. Schneider et al. (2007) showed 
that transcriptional defects can affect processing. A mutant RNA polymerase I, which 
exhibited a slow initiation and elongation, was produced in yeast and these cells have 
severe defects in pre-RNA processing and assembly. It was proposed that a slower 
elongation rate produces improper recruitment of processing proteins and snoRNA. It has 
long been unclear how t-UTPs affect transcription, but recently a t-UTP, 1A6/DRIM (t-
UTP20), was found to associate with a histone acetyltransferase-like protein, hALP, in 
human cells (Peng et al., 2010, Kong et al., 2011). The hALP is involved in acetylating UBF, 
and by being recruited to 1A6/DRIM, the processome promotes transcriptional initiation 
and, possibly, elongation.  
2.1.3 Chromatin and RNA processing 
The chromatin structure at the RNA polymerase I genes is complex. The silent copies are 
tightly packaged with nucleosomes, with features characteristic for heterochromatin, such as 
the repressive marks H3K9me3, H4K20me3 and DNA methylated CpGs at the promoter. 
The setting of the repressive state is caused by a chromatin remodelling complex, the NoRC 
(Santoro et al., 2002; Zhao et al. 2009). The active copies are heavily transcribed and whether 
canonical nucleosomes are present is debated. Studies in yeast show that no histones or very 
small nucleosomes are present on genes that have RNA polymerase I (Merz et al., 2008; 
Jones et al., 2007). Similarly, it has been proposed that mammalian cells are devoid of 
nucleosomes. UBF, which binds to the DNA as a dimer, resembles a nucleosome and may be 
the major chromatin protein in active rDNA in (Sanij and Hannan, 2009). However, histone 
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chaperones in the FACT complex, which function as elongation factors in RNA polymerase 
II transcription, also influence RNA polymerase I transcription (Birch et al., 2009). Whether 
the chromatin structure constitutes a barrier for RNA polymerase I is unclear. A number of 
chromatin remodelling proteins have been associated with active genes, such as the CSB 
(Cockayes syndrome protein B) (Bradsher et al., 2002; Yuan et al., 2007; Lebedev et al., 2008) 
and B-WICH (Cavellán et al. 2006, Percipalle et al., 2006, Vintermist et al., 2011).  Chromatin 
remodelling factors have been also isolated with the p32 (splicing factor 2–associated 
protein p32), which has been identified as a regulator of the transformation of the 90S 
particle to a 40S and a 60S pre-RNA particle. The p32 is also involved in RNA polymerase II 
splicing, so it is unclear whether the interaction with 13 chromatin remodelling proteins 
stems from p32 in RNA polymerase I or RNA polymerase II transcription. The CSB and B-
WICH are involved in active transcription of ribosomal genes affect histone modification. 
CSB recruits the histone methyltransferse G9a, which results in H3K9me2 histones at 
actively transcribed genes (Yuan et al., 2007). The B-WICH, composed of the WSTF (William 
syndrome transcription factor), the ATPase SNF2h and nuclear myosin 1 (NM1), remodels 
chromatin at the promoter, and allows HAT to associate. The HATs subsequently acetylate 
histone H3, in particular H3K9-Ac. Both H3K9me2 and H3-Ac lead to increased 
transcription. Interestingly, the B-WICH complex also contains RNA processing proteins, 
such as RNA helicase Gu and the Myb-binding protein, and the 45S rRNA (Cavellán et al. 
2006). Further analysis has shown that also the snoU3 associates with the complex (Figure 
5A) and the B-WICH subunits can be linked to the 45S rRNA on the gene (Figure 5B). NMI 
binds RNA and is important for the export of the 60S subunit (Obrdlik et al., 2010), 
indicating that it is loaded onto the RNA via a chromatin-remodelling complex at the 
promoter and along the gene. It then follows the 60S pre-ribosome, when the 90S pre-18S-
processome is cleaved off, through assembly and export. 
 
 
Fig. 5. B-WICH associates to RNA. A) IP of WSTF from HeLa cell nuclear extract, from 
which RNA was purified, converted to cDNA using random primers, and analysed by PCR 
with primers specific of U3-RNA and U5-RNA. (Control is no Antibody). B) RNA 
immunoprecipitation of cross-linked chromatin, antibodies against the proteins indicated 
above the lanes. PCR was performed at the genes indicated to the left. 
Even though the B-WICH is not regarded as a t-UTP, some aspects resemble such a 
complex, a model has been proposed, where the complex affects transcription by chromatin 
remodelling, whereas other components are acting on processing (Figure 6). 
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Fig. 6. Chromatin remodelling in ribosomal transcription. The chromatin remodelling 
complex B-WICH assembles at the promoter and interacts with RNA processing factors and 
RNA during transcription. 
2.2 Summary 
The different steps, transcription, processing and export, in ribosomal biogenesis are tightly 
linked. The assembly of the processing factors, such as RNA helicases and snoRNP, are 
important, recognising structures in the rRNA and other proteins. An increasing number of 
“processing” factors are recruited at the promoter and these affect both processing and 
transcription. Even chromatin remodelling factors act as processing factors, function to 
remodel chromatin at the promoter and provide processing and export factors to the 
processomes. The B-WICH is one such example, with the main function in chromatin 
remodelling, but associates with several RNAs and processing proteins. Another is the 
hALP t-UTP. The function of the t-UTP is still unknown, so more factors with functions both 
in chromatin remodelling and RNA processing may exist. 
3. Conclusions 
Nuclear processes are tightly coupled and coordinated. Several lines of evidence now show 
that most RNA processing, both the action of RNA polymerase I and that of RNA 
polymerase II, is performed co-transcriptionally (Staley and Woolford, 2009). Both processes 
comprise RNA polymerases producing RNP particles, in which the RNA is to be matured. 
The machineries are different but many principles of action resemble one another. 
Transcription and RNA processing are influencing one another, conducted in the vicinity of 
one another, and some proteins bind to polymerases and the growing RNA at the same 
time, influencing both transcription and processing. Many of these interactions, such as 
interactions with proteins recruited to the RNA polymerase II, are dynamic and need 
changing for the next step to proceed. The organisation of the chromatin structure at the 
transcribed genes has now emerged as a further component in the network, both in RNA 
polymerase I and RNA polymerase II transcription. In RNA polymerase I transcription, it is 
likely that UBF, together with histone proteins, takes on the role of nucleosomes in RNA 
polymerase II transcription. Recent results demonstrate that histone modifications regulate 
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both the elongation rate and the recruitment of processing proteins to the RNA. 
Furthermore, the RNA can also recruit chromatin proteins, making RNA processing a 
complex network of protein and RNA interactions regulated by phosphorylations, 
acetylation, methylation and small GTPases.   
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